5-(5-acetyl-2-propoxy-3-pyridinyl)-3-ethyl-2-(1-methylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one
C23H30N6O3 — CID 135505815
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(5-acetyl-2-propoxy-3-pyridinyl)-3-ethyl-2-(1-methylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one
5-(5-acetyl-2-propoxy-3-pyridinyl)-3-ethyl-2-(1-methylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one (PubChem CID 135505815) has the molecular formula C23H30N6O3 and a molecular weight of 438.53 g/mol. Its IUPAC name is 5-(5-acetyl-2-propoxy-3-pyridinyl)-3-ethyl-2-(1-methylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one.
Molecular Properties
| Compound Name | 5-(5-acetyl-2-propoxy-3-pyridinyl)-3-ethyl-2-(1-methylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 135505815 |
| Molecular Formula | C23H30N6O3 |
| Molecular Weight | 438.53 g/mol |
| Exact Mass | 438.24 |
| IUPAC Name | 5-(5-acetyl-2-propoxy-3-pyridinyl)-3-ethyl-2-(1-methylpiperidin-4-yl)-6H-pyrazolo[4,3-d]pyrimidin-7-one |
| SMILES | CCCOc1ncc(C(C)=O)cc1-c1nc2c(CC)n(C3CCN(C)CC3)nc2c(=O)[nH]1 |
| InChI | InChI=1S/C23H30N6O3/c1-5-11-32-23-17(12-15(13-24-23)14(3)30)21-25-19-18(6-2)29(27-20(19)22(31)26-21)16-7-9-28(4)10-8-16/h12-13,16H,5-11H2,1-4H3,(H,25,26,31) |
| InChIKey | KTMCUMTWTVVHGC-UHFFFAOYSA-N |
| XLogP | 3.00 |
| TPSA | 106.00 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 438.53 |
| LogP ≤ 5 | 3.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135505815 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.